Select Publications
Conference Papers
2022, 'Capturing Clinical Reasoning in Real Time Reveals Low Rate of Serious Adverse Reactions Requiring B/tsDMARD Discontinuation in Inflammatory Joint Disease: An Analysis of the OPAL Real-World Dataset', in ARTHRITIS & RHEUMATOLOGY, WILEY, pp. 115 - 116, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000877386500069&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Real-world Utilisation and Switching Between Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in the Australian OPAL Dataset', in ARTHRITIS & RHEUMATOLOGY, WILEY, pp. 521 - 522, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000877386500274&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'IDENTIFICATION OF ADULT PATIENTS DIAGNOSED WITH RHEUMATIC MUSCULOSKELETAL DISEASE AS CHILDREN OR ADOLESCENTS IN THE AUSTRALIAN OPAL DATASET', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 18 - 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000799456100044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Modelling of Disease Activity in Patients with Inflammatory Arthropathies Treated with Etanercept Originator or Biosimilar as First-Line Biologic: A Real-World Observational Study Using the OPAL Dataset', in ARTHRITIS & RHEUMATOLOGY, WILEY, pp. 1738 - 1740, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000744545203095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'TREATMENT PATTERNS OF b/tsDMARDs FOR THE MANAGEMENT OF PSORIATIC ARTHRITIS IN AUSTRALIA: AN ANALYSIS OF THE OPAL DATASET', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 28 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000651518500073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'MODELLING LONGITUDINAL PATIENT-REPORTED OUTCOME MEASURES IN JDM', in RHEUMATOLOGY, OXFORD UNIV PRESS, SCOTLAND, Glasgow, pp. 8 - 8, presented at Annual Conference of the British-Society-for-Rheumatology (BSR), SCOTLAND, Glasgow, 20 April 2020 - 22 April 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000534330300018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'RELATIVE MONOCYTE SUBSET DIFFERENCES BETWEEN JUVENILE- AND ADULT-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS', in ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, SPAIN, Madrid, pp. 1571 - 1571, presented at Annual European Congress of Rheumatology (EULAR), SPAIN, Madrid, 12 June 2019 - 15 June 2019, http://dx.doi.org/10.1136/annrheumdis-2019-eular.4089
,2019, '81 Identifying and predicting novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models', in Abstracts, BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, presented at GOSH Conference 2019, Care of the Complex Child, http://dx.doi.org/10.1136/archdischild-2019-gosh.81
,2018, 'INVESTIGATING MITOCHONDRIAL DYSFUNCTION IN JUVENILE DERMATOMYOSITIS', in RHEUMATOLOGY, OXFORD UNIV PRESS, ENGLAND, Southampton, pp. 1 - 1, presented at Conference of the British-Society-for-Rheumatology-Paediatric-and-Adolescent-Rheumatology (BSPAR), ENGLAND, Southampton, 17 October 2018 - 18 October 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000448055600002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'JDM FAMILY DAY: BRINGING TOGETHER YOUNG PEOPLE AND THEIR FAMILIES TO SHARE EXPERIENCES OF JUVENILE DERMATOMYOSITIS (JDM) AND PROVIDE A POSITIVE SUPPORT NETWORK', in RHEUMATOLOGY, OXFORD UNIV PRESS, ENGLAND, Southampton, presented at Conference of the British-Society-for-Rheumatology-Paediatric-and-Adolescent-Rheumatology (BSPAR), ENGLAND, Southampton, 17 October 2018 - 18 October 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000448055600016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Expression of Myxovirus-Resistance Protein a: A Possible Marker of Muscular Disease Activity in Juvenile Dermatomyositis', in ARTHRITIS & RHEUMATOLOGY, WILEY, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000411824105178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'The Interaction between Genetic Risk Factors and Age of Disease Onset in Juvenile Dermatomyositis', in ARTHRITIS & RHEUMATOLOGY, WILEY, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000411824105183&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Transcriptomic Analysis Reveals Mitochondrial and Monocyte Dysfunctions Are Linked to the Interferonopathy of Juvenile Dermatomyositis', in ARTHRITIS & RHEUMATOLOGY, WILEY, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000411824105184&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'INVESTIGATING THE ASSOCIATION BETWEEN SERUM INFLAMMATION-RELATED PROTEINS AND MUSCLE HISTOPATHOLOGICAL SEVERITY IN JUVENILE DERMATOMYOSITIS', in RHEUMATOLOGY, OXFORD UNIV PRESS, ENGLAND, Manchester, presented at Annual Conference Research and Clinical Meeting of the British-Society-for-Paediatric-and-Adolescent-Rheumatology (BSPAR), ENGLAND, Manchester, 29 November 2016 - 30 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423736000004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Analysis of Efficacy and Safety of Cyclophosphamide in Juvenile Dermatomyositis Using a Large National UK Cohort', in ARTHRITIS & RHEUMATOLOGY, WILEY, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000417143405326&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Efficacy and Safety of Tumour Necrosis Factor Antagonists in a Large Cohort of Juvenile Dermatomyositis Patients', in ARTHRITIS & RHEUMATOLOGY, WILEY, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000417143402182&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Peripheral Blood B Cells Are Expanded and Their Cytokine Expression Is Dysregulated in Juvenile Dermatomyositis', in ARTHRITIS & RHEUMATOLOGY, WILEY, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000417143403281&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Transcriptomic Analysis of Immune Subsets in Juvenile Dermatomyositis before and after Treatment Identifies Novel Pathways Involved in Pathogenesis', in ARTHRITIS & RHEUMATOLOGY, WILEY, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000417143404056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Impact of next-generation sequencing error on analysis of barcoded plasmid libraries of known complexity and sequence', in Nucleic Acids Research, http://dx.doi.org/10.1093/nar/gku607
,